Creating safer and more affordable catalysts for chemical reactions
Official title: Development of Base Metal Pre-catalysts for Applications in Catalytic Reaction Discovery
Funded at University of Michigan at Ann Arbor · NIH-10996293 · Data updated 2026-11-12
This study is working on creating safer and cheaper alternatives to a costly metal used in making medicines, by using more common metals like iron and copper, which could help make drug development easier and better for everyone.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | February 1, 2025 |
| Project end | January 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $42,052 |
| NIH project number | 1F31GM155992-01 |
| Project ID | NIH-10996293 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients who may benefit from this research are those requiring medications developed through more efficient and sustainable chemical processes.
✕Less likely to help
Patients who are not involved in pharmaceutical treatments or those whose conditions do not rely on chemically synthesized drugs may not receive direct benefits from this research.
What this research studies
This research focuses on developing new base metal pre-catalysts that can replace the toxic and expensive palladium used in chemical reactions, particularly in pharmaceutical research. By utilizing more abundant metals like iron, cobalt, nickel, and copper, the project aims to create stable and accessible pre-catalysts that can facilitate a variety of chemical transformations. This could lead to more efficient and sustainable methods for drug development, ultimately benefiting the pharmaceutical industry and patients alike. The approach involves synthesizing these pre-catalysts to ensure they are easy to use and effective in various applications.
Why it matters
Potential benefit: If successful, this research could lead to safer and more cost-effective methods for producing pharmaceuticals, potentially lowering drug prices and improving accessibility for patients.
How similar studies have gone: While there has been limited prior research on base metal pre-catalysts, this approach is innovative and aims to address existing challenges in the field.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Thedford, Joshua — University of Michigan at Ann Arbor
- Study coordinator: Thedford, Joshua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.